These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 10713848

  • 21. [Measles--atypical course and complications].
    Baumgarten R.
    Z Arztl Fortbild (Jena); 1991 Jun 25; 85(12):583-5. PubMed ID: 1681623
    [No Abstract] [Full Text] [Related]

  • 22. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990-2002.
    Miller C, Andrews N, Rush M, Munro H, Jin L, Miller E.
    Arch Dis Child; 2004 Dec 25; 89(12):1145-8. PubMed ID: 15557053
    [Abstract] [Full Text] [Related]

  • 23. Subacute sclerosing panencephalitis in Bulgaria (1978-2002).
    Bojinova V, Dimova P, Belopitova L, Mihailov A, Gatcheva N, Mihneva Z, Todorova M.
    Neuroepidemiology; 2004 Dec 25; 23(5):254-7. PubMed ID: 15316253
    [Abstract] [Full Text] [Related]

  • 24. [The vaccination against measles: effectiveness and care in use (author's transl)].
    Battistini FD.
    Ann Sclavo; 1979 Jun 25; 21 Suppl 1():394-401. PubMed ID: 42365
    [Abstract] [Full Text] [Related]

  • 25. [Analysis of the correlation between measles and subacute sclerosis panencephalitis (SSPE) before and after introduction of vaccination in Poland].
    Gut W, Naruszewicz-Lesiuk D.
    Przegl Epidemiol; 1992 Jun 25; 46(4):295-301. PubMed ID: 1305779
    [Abstract] [Full Text] [Related]

  • 26. [Immunologic prevention of measles].
    Gasparini V.
    Ann Sclavo; 1983 Jun 25; 24(3):273-89. PubMed ID: 6615036
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Subacute sclerosing panencephalitis: fulminant form].
    Grippo J, Cáceres L, Asís A, Grippo T, Ruprecht B, López M.
    Rev Neurol; 1983 Jun 25; 36(6):536-9. PubMed ID: 12652417
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Subacute sclerosing panencephalitis.
    Br Med J; 1979 Nov 03; 2(6198):1096. PubMed ID: 93011
    [No Abstract] [Full Text] [Related]

  • 33. Subacute sclerosing panencephalitis mortality, United States, 1979-2016: Vaccine-induced declines in SSPE deaths.
    Pallivathucal LB, Noymer A.
    Vaccine; 2018 Aug 23; 36(35):5222-5225. PubMed ID: 30057285
    [Abstract] [Full Text] [Related]

  • 34. [Epidemiology of subacute sclerosing panencephalitis in Okinawa, Japan, 1970-1996].
    Hirayasu K, Nakada Y, Takaesu E, Kamiya K, Hirayama K.
    No To Hattatsu; 1999 Jan 23; 31(1):27-31. PubMed ID: 10025131
    [Abstract] [Full Text] [Related]

  • 35. [Reasons for vaccinating against measles].
    Celers J, Netter R.
    Bull Acad Natl Med; 1982 Jun 23; 166(6):801-7. PubMed ID: 6756595
    [No Abstract] [Full Text] [Related]

  • 36. The upsurge of SSPE--a reflection of national measles immunization status in Pakistan.
    Ibrahim SH, Amjad N, Saleem AF, Chand P, Rafique A, Humayun KN.
    J Trop Pediatr; 2014 Dec 23; 60(6):449-53. PubMed ID: 25232151
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Panencephalitis following measles vaccination.
    Cho CT, Lansky LJ, D'Souza BJ.
    JAMA; 1973 May 28; 224(9):1299. PubMed ID: 4739905
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.